Virtual Bioequivalence: an update from PAGE (+TSD!) [Dissolution / BCS / IVIVC]

posted by mittyri – Russia, 2019-06-21 13:50 (892 d 09:53 ago) – Posting: # 20356
Views: 2,749

Dear All!

here's the update from the latest PAGE meeting:
  1. Model-based approach for group sequential and adaptive designs in parallel and cross-over bioequivalence studies
    AFAIK this one is the most interesting. Authors are INSERM and FDA people. But it looks like their adaptive design cannot control TIE. How come?
  2. Selection of optimal study design based on the bioequivalence simulation study in highly variable drugs
  3. An In Vitro – In Vivo Simulation Methodology for Predicting the Outcome of Bioequivalence Studies
  4. Investigation of the impact of population parameters describing gastric emptying on bioequivalence metrics

Kind regards,
Mittyri

Complete thread:

Activity
 Admin contact
21,778 posts in 4,555 threads, 1,547 registered users;
online 10 (0 registered, 10 guests [including 5 identified bots]).
Forum time: Monday 22:44 CET (Europe/Vienna)

Mediocrity knows nothing higher than itself,
but talent instantly recognizes genius.    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5